Search

Your search keyword '"Mori S"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Mori S" Remove constraint Author: "Mori S" Topic esophageal neoplasms Remove constraint Topic: esophageal neoplasms
81 results on '"Mori S"'

Search Results

1. A comparison of the surgical invasiveness and short-term outcomes between thoracoscopic and pneumatic mediastinoscopic esophagectomy for esophageal cancer.

2. Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma.

3. Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer.

4. Successful thoracoscopic resection of an esophageal bronchogenic cyst.

5. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.

6. Comparison of greater curvature and lesser curvature circular-stapled esophagogastrostomy after esophagectomy in patients with esophageal cancer: a prospective randomized controlled trial.

7. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.

8. Clinical Outcomes of Fully Covered Self-expanding Metallic Stent Placement for Palliation of Incurable Esophageal Cancer With or Without Radiotherapy.

9. Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma.

10. Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.

11. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.

12. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.

13. Ferredoxin Reductase Is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.

14. [A Case of Advanced Esophageal Cancer Patient with Schizophrenia Successfully Treated with Chemoradiation Therapy with S-1 and CDDP].

15. [A Case of Concurrent Cancer of the Esophagus and Stomach with Severe Sepsis following Chemotherapy].

16. Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis.

17. [A Case of Esophageal Cancer in a Patient with CMV Reactivation after Neoadjuvant Chemoradiation Therapy].

18. Clinical significance of mediastinoscope-assisted transhiatal esophagectomy in patients with esophageal cancer.

19. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.

20. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.

21. Development of squamous neoplasia in esophageal iodine-unstained lesions and the alcohol and aldehyde dehydrogenase genotypes of Japanese alcoholic men.

22. Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma.

23. Undifferentiated carcinoma of the esophagus with rapid growth of lymph node. A case report and review of the literature.

24. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.

25. Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma.

26. Identification of a novel human ankyrin-repeated protein homologous to CARP.

27. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus.

28. [Results of surgical treatment for thoracic esophageal cancer with reference to a randomized controlled trial].

29. Tissue subtraction DNA in situ hybridization (TSDISH): in situ detection of DNA abnormalities in formalin-fixed paraffin-embedded tissue sections by subtraction hybridization with whole genomic DNA.

30. Cytokeratin immunolocalization and lectin binding studies in oesophageal squamous dysplasia.

31. Basaloid-squamous carcinoma of the esophagus. A clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases.

33. [A case report of small cell carcinoma of the esophagus with remarkable response to neoadjuvant chemotherapy].

34. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.

35. Lymph flow and lymph node metastasis in esophageal cancer.

36. Accumulation of genetic alterations during esophageal carcinogenesis.

37. DNA ploidy in human esophageal squamous dysplasias and squamous cell carcinomas as determined by image analysis.

38. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification.

39. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

40. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.

41. Adjuvant therapies for cancer of the thoracic esophagus.

42. [Four cases of phrenic nerve paralysis following surgery of thoracic esophageal carcinoma].

43. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus.

44. [Strategic lymph node dissection for thoracic and abdominal esophageal carcinoma in relation to nodal metastasis and location of carcinoma--analysis of subgroups carcinoma location].

45. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.

46. p53 immunolocalization in cytology specimens: a study in human esophageal carcinoma.

47. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides.

48. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.

49. [Multidisciplinary treatment of cancer of the esophagus].

50. Molecular and cellular features of esophageal cancer cells.

Catalog

Books, media, physical & digital resources